Our platform is empowering top pharmaceutical companies and clinical research organizations to streamline regulatory processes and ensure compliance
Join iViReg News for weekly alerts validated by local experts — delivered straight to your inbox.
Start with a free News subscription, or explore premium plans for deeper
pharmacovigilance regulatory intelligence.
iViReg empowers the pharmacovigilance community by leveraging a global network of experts, offering local regulatory interpretations, support documentation, and reference links, all conveniently translated into English.
No more struggling with disjointed data – iViReg consolidates everything you need in one place.
Achieve Audit Readiness with iViReg’s GxP-validated environment.
Seamlessly manage and assess news alerts through iViTracker, complete with full documentation.
Enjoy rapid Full-Text Search and easily printable reports to streamline your processes.
iViReg Business Owner at iVigee, Paulina, explains a few cool features here...
Pharmacovigilance (PV) ensures the safety of medicines by monitoring and assessing adverse drug reactions (ADRs) as well as other safety measures throughout the product lifecycle. This includes activities during clinical trials, marketing authorization, and post-authorization phases, covering risk management, periodic safety updates, signal detection, and regulatory compliance. Regulatory intelligence in PV helps organizations stay compliant with evolving requirements, enabling them to understand and implement national and global safety regulations effectively.
iViReg provides a centralized platform for pharmacovigilance regulatory intelligence in more than 100 countries, consolidating local and global regulatory requirements, expert insights, and verified regulatory documents. By offering structured data and continuous updates, iViReg helps pharmaceutical companies navigate complex compliance requirements efficiently.
iViReg gathers intelligence through a network of over 100 local PV experts, ensuring a deep understanding of national regulations and real-world implementation. All collected data undergoes rigorous quality control by iVigee’s internal PV Regulatory Intelligence team, who verify source documents and cross-check information against primary regulatory evidence. Additionally, iViReg weekly monitors regulatory agencies and international bodies to ensure the latest updates are incorporated.
Each response in iViReg includes the latest verification date and provides a historical record of changes. Updates are systematically reviewed through continuous monitoring of national regulatory agencies and expert assessments, ensuring the most current and reliable information is available.
iViReg covers the entire lifecycle of medicinal products, from clinical trials to post-authorization requirements. Key areas include ICSR reporting, aggregate safety reports, local QPPV requirements, PSMF obligations, risk management, signal detection, safety communications, and post-authorization measures. The structured database ensures comprehensive regulatory intelligence for PV professionals.
Yes! iViReg enables users to compare PV regulatory intelligence across multiple countries, helping to navigate diverse compliance landscapes. However, access to comparison features starts when a user has more than one country included in their subscription package.
Yes! iViReg is GxP-validated to comply with 21 CFR Part 11: Electronic Records; Electronic Signatures, and EudraLex Volume 4; Annex 11: Computerised Systems. iViReg supports audit trails that give you a response to any inspection request.
Yes! iViReg provides access to local PV regulations in their original language, either as downloadable documents or through direct reference links. Additionally, an increasing number of these documents are translated into English to support global accessibility.
Yes! iViReg allows users to download or print country-specific regulatory intelligence. Information can be exported in Excel (.xlsx) format for analysis or saved as a PDF for documentation and compliance purposes.
This feature provides exclusive insights from local experts and Competent Authorities, offering deeper regulatory understanding beyond publicly available sources.
PV regulatory intelligence ensures organizations involved in medicinal product development and safety remain informed about local ADR reporting requirements, including what must be reported, timelines, submission formats, and language specifications. This knowledge is essential for maintaining compliance with national and regional regulations.
Select any available 30-minute time slot in the calendar and our colleagues will send you an invite for Teams to show you the product for your convenience. No Chatbots! Just ask a team member during the demo for your desired outcomes.
Simple form opens, fill your name and e-mail. We will send you a login into iViReg within 1 business day. You will also start receiving the Reg Intel Highlights prepared every Monday by iViReg team right into your mailbox. Unsubscribe anytime, no credit card needed.